HOSP || Hematology/Thrombosis

Novel anticoagulants get nod in new AF guidelines

Posted on: 28/03/2014 - 18:45

New guidelines for managing patients with nonvalvular atrial fibrillation recommend dabigatran, rivaroxaban, and apixaban, as well as warfarin, and call on physicians to use a more comprehensive...

Field of Interest: Cardiology

Type: News Item

Apixaban approved for preventing DVT and pulmonary embolism after hip/knee surgery

Posted on: 14/03/2014 - 20:15

The oral anticoagulant apixaban has been approved for prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in patients who have undergone hip or knee replacement...

Field of Interest: Cardiology

Type: News Item

FDA reviewers support approval of platelet inhibitor cangrelor for PCI indication

Posted on: 10/02/2014 - 20:35

The data on cangrelor support approval of the fast-acting antiplatelet drug for reducing thrombotic cardiovascular events in patients with coronary artery disease who are undergoing percutaneous...

Field of Interest: Cardiology

Type: News Item

Genotyping adds little to optimized warfarin dosing

Posted on: 03/01/2014 - 14:20

DALLAS – Genotyping to guide the starting dosage of warfarin treatment showed no added value above tailoring treatment with a panel of clinical features in a randomized, controlled U.S. trial of more...

Field of Interest: Cardiology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Novel anticoagulants get nod in new AF guidelines

Apixaban approved for preventing DVT and pulmonary embolism after hip/knee surgery

FDA reviewers support approval of platelet inhibitor cangrelor for PCI indication

Genotyping adds little to optimized warfarin dosing

Newsletters

Latest Newsletters